Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapid Initiation of Buprenorphine/Naloxone for MAT in Philadelphia
NCT03908437Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Jul 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine + naloxone in opioid use disorder (OUD), sponsored by University of Pennsylvania. Started Jul 2019; status: completed.
02
Drugs
buprenorphine + naloxone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03908437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03908437.